Deputy Director of the Division of Ageing Biology at the National Institute on Ageing, which is part of the National Institutes of Health
Ronald Kohanski on KCRW
More from KCRW
A “meaningful” election where neither candidate condemns U.S.-sponsored genocide?
PoliticsIn this spirited debate on the Scheer Intelligence podcast, host Robert Scheer spars with Jeff Cohen—author, co-founder of RootsAction.org, founder of FAIR (Fairness and Accuracy in…
New AI laws, San Francisco politics, ‘Entitlement’ novel
InternationalThe U.S. says Israel was behind this week’s remote detonations of Hezbollah’s communication devices. How was the operation pulled off?
Election results in Orange County could reshape Congress
Orange CountyThe outcome of congressional races in Orange County could determine whether Republicans keep their majority in the House of Representatives.
Juan Cole: Where is the Middle East Heading?
PoliticsIn the 365 days following the events of Oct. 7, the situation in the Middle East is as complicated as ever.
The enviable life of a true American publisher
PoliticsFewer people in the world had access to the personal moments experienced by Steve Wasserman, Heyday Books publisher, former LA Times Book Review editor and former editor at several of…
Criminal justice reform hits a backlash this election season
Election 2024Four years after protesters called to defund the police, voters worried about crime are poised to toss out a reformer D.A. and pass a tough-on-crime bill.
Chasing the Watermelon Man
Food & DrinkAn audio folk story examining the tradition of Black watermelon long-haulers, who drive to farms in the South for watermelon and sell them in Black neighborhoods around the US.
Should we re-frame our idea of ‘working class’ voters?
PoliticsDoes “working class” mean what it used to? Is fracking getting more attention than it deserves? Plus, KCRW examines what came out of one culture war in Lancaster, Pennsylvania.
Irvine police buys $150K Cybertruck, critics call it unnecessary
LawThe Irvine Police Department purchased a Tesla Cybertruck to promote its D.A.R.E drug program. But some taxpayers say the money should be spent elsewhere.